CardioSphere

Introducing BIOTRONIK CardioSphere

Image
CardioSphere Cardiac Patient Management Digital Health

One Portfolio to Advance Cardiac Patient Management

BIOTRONIK has been a leader in remote patient management for more than two decades and continues to be committed to advancing cardiac care with you.

We have designed our CardioSphere portfolio, with its five solutions, for you and your patients to achieve better care. The featured solutions aim to deliver ease of use, insightful data, digital patient engagement and streamlined data flow throughout the entire patient journey.


Connecting the Dots for Seamless Cardiac Care


Supporting You Throughout the Patient Care Journey

The CardioSphere portfolio supports you throughout four phases of the patient care journey

  • Identify: Facilitating initial diagnosis and determining immediate action needed.
  • Diagnose: Providing the tools to diagnose patients rapidly, remotely and confidently.
  • Treat: Offering a broad range of best-in-class technologies – from IPGs and ICDs to CRT devices.
  • Monitor: Enabling you to monitor your patients 24/7, while remotely collecting and accessing patient information.
CardioSphere Patient Care Journey Digital Health

The CardioSphere Portfolio Is Designed to Improve Patient Care Through:


CardioSphere Ease of Use Icon

Ease of Use

Our remote monitoring technology is designed for easy setup and low maintenance based on plug-and-go functionality – making it easy to get patients on board for automated data transfer.

CardioSphere Insightful Data Icon

Insightful Data

Once your patients are on board, BIOTRONIK CardioSphere solutions provide actionable insights for alert-based remote care and proactive heart failure (HF) management.

CardioSphere Digital Patient Engagement Icon

Digital Patient Engagement

The BIOTRONIK CardioSphere solutions can facilitate greater digital interaction with your patients, allowing them to play a more active role in their own care.

CardioSphere Digital streamlined Data Flow

Streamlined Data Flow

CardioSphere solutions transfer and incorporate generated data within the proper context – giving you access to the required data in the right place.


CardioSphere Solutions

BIOTRONIK CardioSphere encompasses our proven devices, the reliable BIOTRONIK Home Monitoring® platform, and digital patient interaction. It is divided into five solutions – all designed to help you advance workflow automation, patient engagement and early detection.

Remote Patient Management​

Long-Term Heart Monitoring

AF Management

Heart Failure Management

Data Management

Remote Patient Management​

BIOTRONIK Remote Patient Management​ Solution

The BIOTRONIK Remote Patient Management Solution includes connected implantsBIOTRONIK Home Monitoring system, a secure plattform, and the BIOTRONIK Patient App, a symptoms tracker application. 

CardioSphere Solution Remote Patient Management

BIOTRONIK Home Monitoring and Patient App Offers:

  • Easy for patients: Patient compliance is essential for effective long-term cardiac monitoring​.
  • Efficient for clinicians: Save time for those patients who need you most​.
  • Actionable for better outcomes: Proven technology for well-informed decision making.1
Patient Care Journey CardioSphere

Key Benefits

  • Reliable data transmission from day one: 98% transmission success.2
  • >60% reduction in all-cause mortality for patients with ICD and CRT-D devices.1
  • BIOTRONIK Home Monitoring and the Patient App bring rhythm and symptom recording together in one platform.

 

Learn More About the Products

BIOTRONIK Home Monitoring Patient App Digital Health

With BIOTRONIK Home Monitoring, clinicians are alerted to worsening patient status early on, giving them time to intervene proactively.

Edora 8 BIOTRONIK Cardiac Device IPG

An implantable pulse generator (IPG) aims to restore a regular sinus rhythm by using small electrical impulses. 

Acticor 7 DR-T

An implantable cardioverter defibrillator (ICD) is able to sense, detect and treat life-threatening cardiac arrhythmias.

BIOTRONIK Acticor 7 HF-T/QP

Cardiac resynchronization therapy (CRT) improves left ventricular function and clinical conditions in selected heart failure patients by the pacing of both ventricles.

Long-Term Heart Monitoring

BIOTRONIK Long-Term Heart Monitoring Solution

The BIOTRONIK Long-Term Heart Monitoring Solution includes BIOMONITOR IIIm, an insertable monitor, the BIOTRONIK Home Monitoring system, and the BIOTRONIK Patient App.

CardioSphere Solution Long Term Heart Monitoring

The RIGHT Data at the RIGHT Time

The BIOTRONIK Long-Term Heart Monitoring Solution is designed to enable you to make informed decision earlier. It aims to help you effectively manage your patients remotely and improve clinical outcomes.

  • 95% p-wave visibility comparable with gold-standard 12-lead electrocardiogram (ECG) for accurate diagnosis.3
  • RhythmCheck® algorithm reduces up to 72% of false-positive AF episodes saving time in FP alerts review.2
  • 5.5 years longevity allows you to monitor AF in cryptogenic stroke and AF postablation long-term.
  • Automatic pairing of Home Monitoring and BIOMONITOR IIIm after implantation.
  • 98% transmission success, leading to the highest patient compliance and lower troubleshooting incidence.4
  • Symptom data added in your Home Monitoring Service Center (HMSC) for evaluating symptoms in relation to rhythm episodes recorded by BIOMONITOR IIIm.
  • Transmission, battery and device information in the app are designed to reduce clinical call burden. 

 

Patient Care Journey CardioSphere

Learn More About the Products

BIOTRONIK Home Monitoring Patient App Digital Health

With BIOTRONIK Home Monitoring, clinicians are alerted to worsening patient status early on, giving them time to intervene proactively.

Implantable cardiac monitors (ICM) are small devices used for long-term monitoring of a patient's heart electrical activity to detect arrhythmia. 

AF Management

BIOTRONIK AF Management Solution

The BIOTRONIK AF Management Solution includes implantable cardioverter-defibrillator (ICD) devices featuring our unique DX technology, the BIOTRONIK Home Monitoring system and the BIOTRONIK Patient App.

.

CardioSphere Solution AF Management

BIOTRONIK DX Systems Offer:

  • Stable, reliable atrial sensing with the simplicity of a single-lead.5,6,*
  • Complete intracardiac electrograms (IEGMs), with atrial channel for improved diagnostics​.7,8,9
  • With CRT-DX, the possibility for two-lead cardiac resynchronization therapy (CRT) when atrial pacing is not required.
Patient Care Journey CardioSphere

Key Benefits

  • Better and earlier tachyarrhythmia/atrial fibrillation (AT/AF) detection,8,9 completed with AT/AF monitoring, supporting improved patient care.8
  • With DX ICD, patients could benefit from the European AF guidelines on atrial high-rate episode (AHRE) monitoring to initiate timely anticoaugulation for stroke prevention.7
  • Timely intervention for AF management reduces the risk of further complications and related hospitalization when coupled with Home Monitoring.10,11
  • Using the Patient App** enriches the data by giving clinicians access to patient-reported symptoms in addition to the clinical rhythm data – for a complete diagnostic assessment and an increased ability to respond more quickly to changes in patient's condition.***

Learn More About the Products

DX technology is a unique, single-lead ICD system enhanced with atrial sensing.

.

BIOTRONIK Home Monitoring Patient App Digital Health

With BIOTRONIK Home Monitoring, clinicians are alerted to worsening patient status early on, giving them time to intervene proactively.

Heart Failure Management

BIOTRONIK Heart Failure Management Solution

The BIOTRONIK Heart Failure Management Solution includes connected implants, the BIOTRONIK Home Monitoring systemHeartInsight and the BIOTRONIK Patient App

CardioSphere Solution Heart Failure Management

Highlights of HeartInsight – Heart Failure Management Solution

  • One accurate alert: For identifying patients at higher risk of worsening heart failure​.
  • One insightful dashboard: For supporting confident decision making​.
  • One step ahead: For initiating a meaningful change.
Patient Care Journey CardioSphere

Key Benefits

  • 66% alert sensitivity, predicting two out of three heart failure hospitalizations.12
  • 42 days' (median) alert time for proactive care.12
  • 0.7 false alert rate per patient year (only one false alert every 17 months).12
  • Low alert burden, with <1 alert per patient year (ppy).13

 

Learn More About the Products

BIOTRONIK Home Monitoring Patient App Digital Health

With BIOTRONIK Home Monitoring, clinicians are alerted to worsening patient status early on, giving them time to intervene proactively.

HeartInsight

HeartInsight is a premium remote heart failure management solution that identifies patients at higher risk of decompensation early on. 

Acticor 7 DR-T

An implantable cardioverter defibrillator (ICD) is able to sense, detect and treat life-threatening cardiac arrhythmias.

BIOTRONIK Acticor 7 HF-T/QP

Cardiac resynchronization therapy (CRT) improves left ventricular function and clinical conditions in selected heart failure patients by the pacing of both ventricles.

Data Management

BIOTRONIK Data Management Solution

The BIOTRONIK Data Management Solution includes CardioMessengerReportShare and DataSync Adapter, supporting streamlined data flow from in-office visits and BIOTRONIK Home Monitoring to your electronic health record (EHR) system.

CardioSphere Solution Data Management

BIOTRONIK Data Management Solution Offers:

  • Automation: Less data entry work for staff​.
  • Centralization: Easy access to patient data​.
  • Integration: Compatible with existing IT setups.
Patient Care Journey CardioSphere

Key Benefits

  • Automatic data handling for in-office visits and BIOTRONIK Home Monitoring​.
  • Centralization via BIOTRONIK DataSync to access the data where you need it.
  • BIOTRONIK data sources observe IEEE/HL7 IDCO and the latest cybersecurity standards.

 

Learn More About the Products

BIOTRONIK DataSync simplifies the way patient information is stored and accessed at your hospital, saving you and your staff time.


Do You Have Questions? Contact Us

The data you provide will be processed for the purpose of handling your request in accordance with our BIOTRONIK Privacy Statement.


Disclaimer and References

1. Hindricks G et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomized controlled trial. The Lancet. 2014; 384 (9943): 583–590.
2. Mariani JA et al. Miniaturized implantable cardiac monitor with a long sensing vector (BIOMONITOR III): Insertion procedure assessment, sensing performance, and home monitoring transmission success. Journal of Electrocardiology 60 (2020): 118–125.
3. Deneke T, Cabanas P, Hofer D, Gaspar T, Pierre B, Bisignani G, Pathak RK, Sanfins VM, Martens E, Mansourati J, Berruezo-Sanchez A. New Generation Miniaturized Insertable Cardiac Monitor with a Long Sensing Vector: Insertion Procedure, Sensing Performance, and Home Monitoring Transmission Success in a Real-World Population. Heart Rhythm 02. 2022 Jan 30.
4. Lovibond S et al. The BIO|CONCEPT.BIOMONITOR III study: Sensing performance and Home Monitoring transmission success of a new miniaturized implantable cardiac monitor; AP19-00775 – 12th Asia Pacific Heart Rhythm Society Scientific Session: Bangkok 24–27 October 2019.
5. Gwag HB et al. Long-term evaluation of sensing variability of a floating atrial dipole in a single lead defibrillator: The mechanistic basis of long-term stability of amplified atrial electrogram. Int J Cardiol. 2021;336:67–72. doi:10.1016/j.ijcard.2021.05.024.
6. Worden NE et al. Long-Term Stability and Clinical Utility of Amplified Atrial Electrograms in a Single-Lead ICD System with Floating Atrial Electrodes. Pacing Clin Electrophysiol. 2016;39:1327–34. doi:10.1111/pace.12967.
7. Maglia G et al. Capability of guideline-conform remote atrial high-rate episode monitoring with a single-chamber implantable defibrillator with atrial sensing. Europace 2022 Volume 24 Supplement 1.
8. Thomas G et al. Subclinical atrial fibrillation detection with a floating atrial sensing dipole in single lead implantable cardioverter-defibrillator systems: Results of the SENSE trial. J Cardiovasc Electrophysiol. 2019; 30(10): 1994–2001.
9. Biffi M et al. The role of atrial sensing for new-onset atrial arrhythmias diagnosis and management in single-chamber implantable cardioverter-defibrillator recipients: Results from the THINGS registry. J Cardiovasc Electrophysiol. 2020;31(4): 846–853.
10. Mabo P et al. A Randomized Trial of Long-Term Remote Monitoring of Pacemaker Recipients (The COMPAS Trial). European Heart Journal. 2012; 33: 1105–11.
11. Guédon-Moreau L et al., Decreased delivery of inappropriate shocks achieved by remote monitoring of ICD: A sub-study of the ECOST trial. J Cardiovasc Electrophysiol. 2014; 25(7): 763–70.       
12. D’Onofrio A et al. Combining home monitoring temporal trends from implanted defibrillators and baseline patient risk profile to predict heart failure hospitalisations: results from the SELENE HF study. Europace 2021. doi: 10.1093/europace/euab170.
13. Data on file.

 

* Mean sensed atrial amplitude was 8.0 ±5.0 mV at implant and 7.3 ±4.8 mV at 12-month follow-up.      

** Patient's BIOTRONIK cardiac device and the BIOTRONIK Home Monitoring system are completely automatic and function with or without the use of the Patient App. Although the Patient App offers great new functionality, its use is additional, not mandatory, to the BIOTRONIK Home Monitoring system.       

*** The app's full functionality should be accessible when the implanted device communicates with the BIOTRONIK Home Monitoring system, and the patient´s doctor may not always receive patient-documented symptoms. Patients are advised to always consult their doctor before using the BIOTRONIK Patient App or Home Monitoring. 

 

This page may include information about products that may not be available in your region or country. Content on specific BIOTRONIK products is not intended for users in markets that do not have authorization for use.